Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
INCY
Stock Latest News
The Fly
Incyte assumed with an Equal Weight at Morgan Stanley
6d ago
INCY
Premium
Ratings
Incyte’s Future Hinges on Pipeline Potential Amid Jakafi Exclusivity Loss
6d ago
INCY
Premium
Company Announcements
Incyte Announces New CEO William J. Meury
12d ago
8K
INCY
Premium
Ratings
Incyte’s Challenges and Potential Amid Leadership Change and R&D Hurdles
12d ago
INCY
Premium
Ratings
Incyte’s Leadership Transition and Pipeline Uncertainty Justify Hold Rating
13d ago
INCY
Premium
The Fly
Shell denies deal talks with BP, Micron reports Q3 beat: Morning Buzz
13d ago
U
BP
Premium
The Fly
New Incyte CEO fuels M&A speculation, says RBC Capital
13d ago
INCY
Premium
The Fly
Incyte CEO Herve Hoppenot to retire, Bill Meury to succeed
13d ago
INCY
Premium
Ratings
Monjuvi’s Strategic Advantage in Follicular Lymphoma: Analyst Recommends Buy Amid FDA Approval and Projected Revenue Growth
15d ago
INCY
Premium
The Fly
J&J’s ‘968 delay has mixed readthroughs for Incyte’s ‘989, says RBC
16d ago
JNJ
INCY
Premium
Weekend Updates
Sutro, Sarepta, Incyte, Signet, Wix: Trending by Analysts
18d ago
SIG
WIX
Premium
The Fly
Incyte announces FDA extends review period for Opzelura sNDA
19d ago
INCY
Premium
The Fly
Incyte confirms FDA approval of Monjuvi for refractory follicular lymphoma
21d ago
INCY
Premium
The Fly
FDA approves Incyte’s tafasitamab-cxix for refractory follicular lymphoma
21d ago
INCY
Premium
Ratings
Positive Buy Rating for Incyte Driven by Promising INCA33989 Trial Results and Favorable Safety Profile
22d ago
INCY
Premium
The Fly
Sarepta suspends Elevidys shipments, Supernus acquires Sage: Morning Buzz
23d ago
BA
BMY
Premium
The Fly
Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls
23d ago
CE
BSX
Premium
The Fly
Video: Sarepta, Hinge Health among major pre-market movers
23d ago
HNGE
INCY
Premium
Ratings
Incyte’s Strategic and Financial Challenges Prompt Sell Rating Despite Promising Trial Data
23d ago
INCY
Premium
Ratings
Promising Phase 1 Results for Incyte’s INCA033989 Support Buy Rating Amid Strategic Developments
23d ago
INCY
Premium
Ratings
Incyte’s Promising Developments in ET Treatment and Strategic Partnerships Drive Buy Rating
23d ago
INCY
Premium
Ratings
Cautious Optimism for Incyte’s INCA33989 Amid Promising Data and Uncertain Timelines
23d ago
INCY
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
